| 000 | 01800 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516084744.0 | ||
| 264 | 0 | _c20120619 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2012.106 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeun, L G | |
| 245 | 0 | 0 |
_aNegative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cApr 2012 |
||
| 300 |
_a1481-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aArginine _xdeficiency |
| 650 | 0 | 4 |
_aArgininosuccinate Synthase _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrolases _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMarini, A | |
| 700 | 1 | _aWalker, G | |
| 700 | 1 | _aElgart, G | |
| 700 | 1 | _aMoffat, F | |
| 700 | 1 | _aRodgers, S E | |
| 700 | 1 | _aWu, C J | |
| 700 | 1 | _aYou, M | |
| 700 | 1 | _aWangpaichitr, M | |
| 700 | 1 | _aKuo, M T | |
| 700 | 1 | _aSisson, W | |
| 700 | 1 | _aJungbluth, A A | |
| 700 | 1 | _aBomalaski, J | |
| 700 | 1 | _aSavaraj, N | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 106 _gno. 9 _gp. 1481-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2012.106 _zAvailable from publisher's website |
| 999 |
_c21675250 _d21675250 |
||